Epigenetic inactivation of the ERK inhibitor Spry2 in B-cell diffuse lymphomas
- 21 April 2008
- journal article
- Published by Springer Science and Business Media LLC in Oncogene
- Vol. 27 (36), 4969-4972
- https://doi.org/10.1038/onc.2008.129
Abstract
Spry2 has been characterized as a negative regulator of the extracellular-regulated kinase (ERK) pathway. In this study we analysed whether epigenetic alterations of hSpry2 promoter occur in human lymphoid/hematopoietic malignancies. Our results revealed that hSpry2 promoter was hypermethylated in the HT cell line derived from a B-cell diffuse lymphoma, which correlated with decreased hSpry2 expression. We detected deregulation of the ERK pathway in these cells, but not in other blood cell lines expressing hSpry2. In addition, the ectopic overexpression of hSpry2 in HT cells drastically reduced the activation of ERK upon phorbol 12-myristate-13-acetate stimulation. Nude mice inoculated with HT mock cells developed tumors seven times larger than those from HT-hSpry2-transfected cells. We found hypermethylation of hSpry2 promoter in 37% (26 cases out of 71) of primary tumors from patients with B-cell diffuse lymphoma but none in normal B lymphocytes from 37 healthy individuals. Finally, we detected that hSpry2 promoter hypermethylation was associated with a significant decrease in the 5-year survival rate. These data suggest that hSpry2 could be important in lymphoid malignancies.Keywords
This publication has 14 references indexed in Scilit:
- Sprouty proteins, masterminds of receptor tyrosine kinase signalingAngiogenesis, 2008
- Sprouty2 binds Grb2 at two different proline-rich regions, and the mechanism of ERK inhibition is independent of this interactionCellular Signalling, 2007
- Getting a first clue about SPRED functionsBioEssays, 2007
- Sprouty and cancer: The first terms reportCancer Letters, 2006
- A Profile of Methyl-CpG Binding Domain Protein Occupancy of Hypermethylated Promoter CpG Islands of Tumor Suppressor Genes in Human CancerCancer Research, 2006
- Sprouty proteins: multifaceted negative-feedback regulators of receptor tyrosine kinase signalingTrends in Cell Biology, 2006
- A Mouse Skin Multistage Carcinogenesis Model Reflects the Aberrant DNA Methylation Patterns of Human TumorsCancer Research, 2004
- Epigenetics in human disease and prospects for epigenetic therapyNature, 2004
- RasGRP, a Ras Guanyl Nucleotide- Releasing Protein with Calcium- and Diacylglycerol-Binding MotifsScience, 1998
- CpG Islands in vertebrate genomesJournal of Molecular Biology, 1987